Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.
about
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckThe woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infectionImmunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.Immune response and tolerance during chronic hepatitis B virus infection.Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.Molecular viral oncology of hepatocellular carcinoma.Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance.Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunityAdvantages to the use of rodent hepadnavirus core proteins as vaccine platformsChemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.HBV-Specific Adaptive Immunity.The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Tolerance and immunity to pathogens in early life: insights from HBV infection.Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection.KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.Woodchuck hepatitis virus core gene deletions and proliferative responses of peripheral blood mononuclear cells stimulated by an immunodominant epitope: a viral immune escape in the woodchuck model of chronic hepatitis B?Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.Identification of acute self-limited hepatitis B among patients presenting with hepatitis B virus-related acute hepatitis: a hospital-based epidemiological and clinical study.Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B.Dynamics of the Immune Response in Acute Hepatitis B Infection.
P2860
Q26828598-BB90F6E9-609F-4362-9EF9-CD07B08193B3Q33787525-7A1ACCEC-308E-49DE-9FC6-47C82D09BA24Q34365631-BEFB1BEF-1AEC-40B4-BBDA-B563B2F5A94AQ34700332-430CC551-334E-43FC-B4D1-86EE13404137Q34764269-238B6D91-F65B-42FF-B6FD-2881C83F0BA2Q35076712-C919C38C-3F1B-47E5-832E-02A5B359A553Q35196596-B4CC25CF-5C58-4D21-9DC5-5EEF6D407A0AQ35603830-0F8876FF-2021-4156-BB50-0ADDDED1D4B6Q35634911-E3E9534C-DCE5-424B-A2DD-E2540BE3B7CFQ35663329-6E55C801-3AF5-4BEC-805A-57F2F9ABA85DQ36099102-FB50B624-7928-48D0-9940-A772F4C72B93Q36821357-323C0848-21DD-413E-9C14-B4C559BBAC31Q36980731-9DA7E0B0-6B51-401F-B480-C063C8BF9F1DQ37099867-5134D0D0-09F5-4BED-8028-7E47CA8D34D1Q37195244-2E448944-3276-45D5-8E06-1FDF4E40AF77Q37452091-B7513374-D173-4D71-B951-3246DA806CA0Q38613247-A97431D8-C820-4E13-AAF5-75114FB679E3Q38618869-46B2C5AA-C822-4357-85D6-A38279836998Q39419957-7A2EC067-43C6-45C3-B1DB-316DA95A948FQ39764120-5606C811-F2BA-47CA-A42D-C7BD1EF465EDQ40738987-6B154D2B-6102-4880-8394-2156E50C5067Q41218508-3C8C8C09-B13F-4B97-BED2-4699EBCDC9F9Q41493609-109AC528-A96A-46E0-B19A-5950E8FBEFA3Q42129273-BDC73863-FA93-4CBC-9A8E-3191A3FF6C73Q42416375-1090893A-56DE-45C0-BA01-D4E40EF5F919Q42431867-55201A34-E3B0-423A-81C5-B648D6F554A5Q44186641-0EE32C7B-F077-4FEE-BC47-9D18486FE869Q45591313-128EE8ED-75AF-4640-A14C-F6AFC8ACBF7FQ46514345-3E4EF391-9BA1-4A68-8B9F-29DC0F69894CQ47165468-F1470E7E-3CEE-4ED9-A460-079129DE4B27
P2860
Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@ast
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@en
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@nl
type
label
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@ast
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@en
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@nl
prefLabel
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@ast
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@en
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@nl
P2093
P2860
P1433
P1476
Deficiencies in the acute-phas ...... ollowing neonatal inoculation.
@en
P2093
Bud C Tennant
Carol A Roneker
John L Gerin
Michael Roggendorf
Paul J Cote
Stephan Menne
P2860
P304
P356
10.1128/JVI.76.4.1769-1780.2002
P407
P577
2002-02-01T00:00:00Z